Document is current
Any future updates will be listed below
-
Authors
Gonzalez-Exposito, Reyes
Semiannikova, Maria
Griffiths, Beatrice
Khan, Khurum
Barber, Louise J.
Woolston, Andrew
Spain, Georgia
von Loga, Katharina
Challoner, Ben
Patel, Radhika
Ranes, Michael
Swain, Amanda
Thomas, Janet
Bryant, Annette
Saffery, Claire
Fotiadis, Nicos
Guettler, Sebastian
Mansfield, David
Melcher, Alan
Powles, Thomas
Rao, Sheela
Watkins, David
Chau, Ian
Matthews, Nik
Wallberg, Fredrik
Starling, Naureen
Cunningham, David
Gerlinger, Marco http://orcid.org/0000-0003-2719-299X
-
Funding
Funding for this research was provided by:
Sociedad Española de Oncología Médica
- License Information
-
More Information
Article History
Received: 18 December 2018
Accepted: 22 March 2019
First Online: 15 April 2019
Ethics approval and consent to participate
: Human samples were obtained from clinical trial and biobanking protocols which have been approved by the UK National Ethics Committee (Prospect C trial approval number: 12/LO/0914, Prospect R trial approval number: 14/LO/1812, FOrMAT trial approval number 13/LO/1274, Improving Outcomes in Cancer biobanking protocol approval number: 13/EM/0327, approval number for use of buffy coats from the blood bank: 06/Q1206/106). All individuals provided written informed consent for sample donation and use for research.
: All authors read the manuscript and consented to publication.
: Dr. Gonzalez-Exposito was supported by a fellowship grant from the Spanish Society of Medical Oncology for Translational Research in Reference Centers that was funded by Roche (FSEOM/Roche). Dr. Gerlinger receives research funding from Merck KG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
